SEC Form 4 · accession 0001209191-16-118826
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William F Daniel
Director
Period of report
May 6, 2016
Accepted (ET)
May 10, 2016 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 6, 2016 | M | 5,258 | — | A | 10,751 | I | By Trust |
| Ordinary Shares | May 6, 2016 | F | 1,590 | $13.41 | D | 9,161 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 6, 2016 | M | 5,258 | D | — | — | Ordinary Shares | 5,258 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On May 6, 2015, the reporting person was granted 5,258 restricted stock units, vesting in full on the first anniversary of the grant date.